Lincoln Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - FormulationsNSE
₹511.90
-0.15-0.03% (1D)
As on 20 Nov 2026 at 15:59
As of 20 Nov 2026 at 15:59, Lincoln Pharmaceuticals Ltd is trading at ₹511.90. The 52-week range stands at ₹440.00–₹770.00, with a market cap of ₹1.02 thousand crore. At a P/E of 10.56 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

LINCOLN Price Chart

Market Cap
₹1.02K Cr
PE Ratio
10.56
ROCE
15.72%

Lincoln Pharmaceuticals Ltd Performance

Lincoln Pharmaceuticals Ltd Fundamentals

Know More
Market Cap₹1.02K Cr
ROE11.94%
P/E Ratio (TTM)10.56
EPS (TTM)₹48.38
P/B Ratio1.26
Dividend Yield0.00%
Industry P/E91.72
Book Value₹405.16
Debt to Equity0.00
Face Value₹10

Lincoln Pharmaceuticals Ltd Shareholding Pattern

Know More
Promoter49.8%
Foreign Institutions4.5%
Mutual Funds0%
Domestic Institutions0%
Public45.7%

Lincoln Pharmaceuticals Ltd Financial Statements

Know More
No data for this view.

Lincoln Pharmaceuticals Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Limited, was originally registered and formed as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations. The Firm was converted into a Public Company in January 1995 named 'Lincoln Pharmaceuticals Limited' . All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company was initially carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project. The Company launched Next Generation Progesterone Therapy 'ProlinSpray' during the year 2018. During the year 2021-22, Lincoln Parenteral Limited, an erstwhile subsidiary, merged with the Company through Scheme of Amalgamation and Lincoln Parenteral Limited ceased to be a subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022. The Company commenced commercial production in Mehsana in FY 2025. The Cephalosporin products scaled its operations in FY26 at Mehsana. It also commenced the Bulk Drug Manufacturing Plant.

Parent Organisation—
Founded1995
Managing DirectorMahendra G Patel
NSE SymbolLINCOLN

Lincoln Pharmaceuticals Ltd Resistance and Support levels

R3518.08R2515.93R1514.59S1510.28S2508.94S3506.78511.90

Lincoln Pharmaceuticals Ltd Technicals

Current Price
₹511.90 ₹0.15 (-0.03%)
Bearish
12
Bullish
0
  • 20 Day2.1%
  • 50 Day6.3%
  • 100 Day9.9%
  • 200 Day11.7%

Lincoln Pharmaceuticals Ltd Latest News

View More
22 OCT 2026 | Thursday
Lincoln Pharmaceuticals to review quarterly results at board meeting on October 29, 2026
07 OCT 2026 | Wednesday
Lincoln Pharmaceuticals confirms securities dematerialization via MUFG Intime, per NSE and BSE
23 SEPT 2026 | Wednesday
Lincoln Pharmaceuticals Ltd. will halt trading following Q3 2026 results announcement
29 AUG 2026 | Saturday
Lincoln Pharmaceuticals announces final dividend of Rs 1.80 per share, record date set for September 11
29 AUG 2026 | Saturday
Lincoln Pharmaceuticals to hold annual meeting, declares Rs 1.80 per share dividend
06 AUG 2026 | Thursday
Lincoln Pharmaceuticals to review quarterly results at board meeting on August 13, 2026
29 MAY 2026 | Friday
Board of Lincoln Pharmaceuticals recommends final dividend

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Lincoln Pharmaceuticals Ltd is ₹511.90 as of 20 Nov 2026 at 15:59.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now